| __timestamp | Ascendis Pharma A/S | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 13774000 |
| Thursday, January 1, 2015 | 9415000 | 22479000 |
| Friday, January 1, 2016 | 11504000 | 27388000 |
| Sunday, January 1, 2017 | 13482000 | 35610000 |
| Monday, January 1, 2018 | 25057000 | 49007000 |
| Tuesday, January 1, 2019 | 48473000 | 61139000 |
| Wednesday, January 1, 2020 | 76669000 | 68836000 |
| Friday, January 1, 2021 | 160180000 | 97592000 |
| Saturday, January 1, 2022 | 221227000 | 106903000 |
| Sunday, January 1, 2023 | 264410000 | 120998000 |
| Monday, January 1, 2024 | 284545000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, understanding spending patterns is crucial. Over the past decade, Ascendis Pharma A/S and Vericel Corporation have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Ascendis Pharma A/S has seen a remarkable increase, with expenses growing by over 4,100% from 2014 to 2023. This surge reflects their aggressive expansion and investment in operational capabilities. In contrast, Vericel Corporation's SG&A expenses have increased by approximately 780% during the same period, indicating a more measured growth strategy.
By 2023, Ascendis Pharma's SG&A expenses were more than double those of Vericel, highlighting their commitment to scaling operations. These trends offer insights into each company's strategic priorities and market positioning, providing a window into their future growth trajectories.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Gross Profit Trends Compared: Ascendis Pharma A/S vs Vericel Corporation
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Ascendis Pharma A/S or Evotec SE: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights